| |
| |
|
| Insider
Information: |
Cassella James V |
| Relationship: |
Chief Development Offi... |
| City: |
Palo Alto |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
62,495 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
62,495 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexza Pharmaceuticals Inc. |
ALXA |
EVP, R&D and CSO |
2013-03-29 |
62,495 |
2009-02-24 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Chief Development Offi... |
2023-03-06 |
0 |
2017-07-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
33 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2022-01-05 |
4 |
AS |
$3.19 |
$9,232 |
D/D |
(2,894) |
83,084 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2022-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
110,500 |
193,584 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2022-02-14 |
4 |
AS |
$3.09 |
$11,625 |
D/D |
(3,762) |
189,822 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2023-01-06 |
4 |
AS |
$7.25 |
$20,974 |
D/D |
(2,893) |
186,929 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2023-01-30 |
4 |
AS |
$8.35 |
$84,385 |
D/D |
(10,106) |
176,823 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2023-02-15 |
4 |
AS |
$8.34 |
$31,375 |
D/D |
(3,762) |
173,061 |
0 |
% |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,766) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Chief Development Officer |
• – – |
2023-03-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(80,595) |
0 |
0 |
- |
|
33 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
